SCHEMBL7668183

SCHEMBL7668183

NC(=O)c1ccnc(C[O])c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.47
POLB P06746 1/20 0.47
TSHR P16473 2/20 0.46
KDM4E B2RXH2 2/20 0.46
LMNA P02545 1/20 0.46
CYP3A4 P08684 1/20 0.46
KDM5C P41229 5/20 0.46
KDM5B Q9UGL1 4/20 0.46
KDM4C Q9H3R0 3/20 0.46
KDM5A P29375 2/20 0.46
KDM5D Q9BY66 1/20 0.46
KDM4B O94953 2/20 0.45
MBOAT4 Q96T53 1/20 0.44
MKNK1 Q9BUB5 1/20 0.42
MKNK2 Q9HBH9 1/20 0.42
PARP10 Q53GL7 1/20 0.41
GABRP O00591 1/20 0.40
GABRD O14764 1/20 0.40
GABRA1 P14867 1/20 0.40
GABRB1 P18505 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL509023 0.85 CYP1A2 (0.47) CYP1A2POLBTSHRKDM4ELMNA
SCHEMBL8594535 0.85 CYP1A2 (0.47) CYP1A2POLBTSHRKDM4ELMNA
SCHEMBL30607268 0.85 CYP1A2 (0.47) CYP1A2POLBTSHRKDM4ELMNA
SCHEMBL5566822 0.83 CYP1A2 (0.46) CYP1A2POLBTSHRKDM4ELMNA
2-Ethylisonicotinamide SCHEMBL2606610 0.83 CYP1A2 (0.69) CYP1A2POLBTSHRKDM4ELMNA
SCHEMBL15991431 0.83 CYP1A2 (0.46) CYP1A2POLBTSHRKDM4ELMNA
SCHEMBL7670706 0.82 KDM4C (0.57) KDM4EKDM5CKDM5BKDM4CKDM5A
SCHEMBL5147899 0.81 TSHR (0.51) CYP1A2POLBTSHRKDM4ELMNA
SCHEMBL17873933 0.80 KDM4E (0.73) CYP1A2POLBTSHRKDM4ELMNA
SCHEMBL16115747 0.79 KDM4E (0.49) CYP1A2POLBTSHRKDM4ELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6476021-B1 Compounds having cGMP-PDE inhibitory effect MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2002-11-05 US disclosed
EP-1048666-A1 NOVEL COMPOUNDS HAVING cGMP-PDE INHIBITORY EFFECT MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2000-11-02 EP disclosed